Ground-breaking legislation changes to the law last November have relaxed the rules around the use of cannabis in the UK.
WHAT HAS THE UK’S FIRST MEDICAL MARIJUANA FIRM DONE SO FAR?
London-based Sativa Investments, the UK’s first medicinal cannabis investment vehicle, has signed a Memorandum of Understanding with George Botanicals Ltd, a manufacturer, wholesaler and distributor of wellness CBD products, to purchase a 51% shareholding from its owner, Carbon Managers.
Geremy Thomas, founder and Chief Executive Officer of Sativa, comments: “George Botanicals may well be one of Sativa’s maiden investments and could provide an excellent gateway into the UK’s fast-growing CBD retail marketplace.”
Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.